Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02YYF
|
||||
Former ID |
DAP000939
|
||||
Drug Name |
Bretylium
|
||||
Synonyms |
Bretylum; Bretylium tolsylate; Bretylium tosylate(USAN); N-(2-bromobenzyl)-N,N-dimethylethanaminium; N-ethyl-N,N-dimethyl-2-bromobenzenemethanaminium; Benzenemethanaminium, 2-bromo-N-ethyl-N,N-dimethyl-, salt with 4-methylbenzenesulfonic acid (1:1); (2-bromobenzyl)ethyldimethylaminium; (2-bromophenyl)methyl-ethyl-dimethylazanium; (o-Bromobenzyl)ethyldimethylammonium p-toluenesulfonate; 2-bromo-N-ethyl-N,N-dimethylbenzenemethanaminium
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Ventricular fibrillation [ICD10:I49.01] | Approved | [551871] | ||
Therapeutic Class |
Antiarrhythmic Agents
|
||||
Company |
Hospira Inc
|
||||
Structure |
Download2D MOL |
||||
Formula |
C11H17BrN+
|
||||
InChI |
InChI=1S/C11H17BrN/c1-4-13(2,3)9-10-7-5-6-8-11(10)12/h5-8H,4,9H2,1-3H3/q+1
|
||||
InChIKey |
AAQOQKQBGPPFNS-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 59-41-6
|
||||
PubChem Compound ID | |||||
PubChem Substance ID |
9073, 794516, 5580995, 7978814, 8151623, 11468090, 11486799, 14749639, 29221595, 46505320, 47365410, 47515523, 47515524, 48035343, 49699004, 50064953, 50113154, 50113155, 50310316, 57321311, 85209526, 92740966, 104300566, 126407358, 126729469, 127378478, 131273742, 134222665, 134338214, 135021960, 137001461, 142246611, 160964492, 162201420, 175267511, 178103706, 179225252, 223454297, 223518984, 223814627, 225144298, 226405825, 246089195
|
||||
SuperDrug ATC ID |
C01BD02
|
||||
SuperDrug CAS ID |
cas=000061756
|
||||
Target and Pathway | |||||
Target(s) | Beta-1 adrenergic receptor | Target Info | Antagonist | [537646], [537704] | |
PathWhiz Pathway | Muscle/Heart Contraction | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.